C. A. Puliafito
About
In The Last Decade
C. A. Puliafito
28 papers receiving 663 citations
Peers
Comparison fields: 5 of 79
- Ophthalmology 447
- Radiology, Nuclear Medicine and Imaging 387
- Biomedical Engineering 185
- Neurology 62
- Molecular Biology 59
Countries citing papers authored by C. A. Puliafito
This map shows the geographic impact of C. A. Puliafito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. A. Puliafito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. A. Puliafito more than expected).
Fields of papers citing papers by C. A. Puliafito
This network shows the impact of papers produced by C. A. Puliafito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. A. Puliafito. The network helps show where C. A. Puliafito may publish in the future.
Co-authorship network of co-authors of C. A. Puliafito
This figure shows the co-authorship network connecting the top 25 collaborators of C. A. Puliafito. A scholar is included among the top collaborators of C. A. Puliafito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. A. Puliafito. C. A. Puliafito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Evaluation of Potential Pitfalls Related to Operator Errors During OCT Image Acquisition | 1 |
| 2 | Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study | 11 |
| 3 | 5 | |
| 4 | RhuFab V2 (Anti-VEGF Antibody Fragment) in Neovascular AMD: Safety, Tolerability, and Efficacy of Multiple, Escalating Dose Intravitreal Injections | 10 |
| 5 | Treatment of Central Retinal Vein Occlusion with Intravitreal Triamcinolone Acetonide | 1 |
| 6 | Characterization of epiretinal membranes using Optical Coherence Tomography (OCT) | 0 |
| 7 | 20 | |
| 8 | 18 | |
| 9 | 32 | |
| 10 | 74 | |
| 11 | 5 | |
| 12 | In vivo measurements of human retinal structure using optical coherence tomography | 2 |
| 13 | 38 | |
| 14 | 16 | |
| 15 | 78 | |
| 16 | 5 | |
| 17 | 49 | |
| 18 | 5 | |
| 19 | 40 | |
| 20 | Recurrent isolated sixth nerve palsy in children. | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.